News
The newly funded projects explore different underlying causes of Parkinson’s, and work towards new drugs to treat the condition.
In this round of grants, we’ve awarded funding to 2 projects that explore new solutions to manage Parkinson’s symptoms, without the need for extra medication.
A study funded by Parkinson’s UK has shown that a handheld device designed to stimulate the vagus nerve is safe and easy to use for people with Parkinson’s. However, the research found no significant improvements to symptoms.
First participants receive NRG drug, further information on Herantis’ treatment and Syntara trial moves towards the data analysis phase.
We achieved so much in 2025. And it’s all thanks to your support.
Early results from a study of the drug developed by AC Immune offer hope that it could slow the progression of Parkinson's symptoms.
A small clinical trial of a probiotic called Symprove shows it helps with non-motor symptoms of Parkinson’s, changes gut bacteria and improves efficiency of medication.
Today we publish new statistics about Parkinson’s in the UK, highlighting gaps in NHS services.
A new research trial will start by testing 2 potential treatments that could slow or even stop Parkinson’s getting worse.
HER-096, a potential new Parkinson's treatment, has shown promising phase 1 trial results, proving it’s safe, well-tolerated, and effective in reaching the brain in people with Parkinson's. This is a crucial step towards a drug that could slow, stop, or even repair Parkinson's damage.